CINECA IRIS Institutional Research Information System

PEOLA, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.207
EU - Europa 1.452
AS - Asia 767
AF - Africa 63
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 3
SA - Sud America 3
Totale 4.512
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.180
CN - Cina 390
DE - Germania 240
SG - Singapore 227
SE - Svezia 200
UA - Ucraina 177
IT - Italia 162
IE - Irlanda 154
FR - Francia 131
AT - Austria 125
FI - Finlandia 94
KR - Corea 67
SN - Senegal 55
PL - Polonia 51
GB - Regno Unito 43
VN - Vietnam 28
CA - Canada 27
NL - Olanda 21
EU - Europa 17
IN - India 15
ID - Indonesia 11
RU - Federazione Russa 9
BE - Belgio 8
JP - Giappone 8
BY - Bielorussia 7
ES - Italia 6
RS - Serbia 6
UZ - Uzbekistan 6
HK - Hong Kong 5
PK - Pakistan 5
EG - Egitto 4
GR - Grecia 4
PT - Portogallo 4
AU - Australia 3
CH - Svizzera 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
LT - Lituania 2
AR - Argentina 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
HU - Ungheria 1
IR - Iran 1
LU - Lussemburgo 1
PH - Filippine 1
RO - Romania 1
UY - Uruguay 1
Totale 4.512
Salva come PNG Salva come JPEG
Città #
Chandler 303
Beijing 292
Santa Clara 219
Singapore 163
Dublin 153
Jacksonville 149
Vienna 125
Ashburn 96
Nyköping 88
Dearborn 84
Ann Arbor 76
Medford 65
Villeurbanne 62
Houston 58
San Mateo 54
Torino 54
Princeton 53
Fairfield 50
Wilmington 49
Fremont 48
Columbus 46
Warsaw 46
Woodbridge 40
Seattle 28
Toronto 19
Dong Ket 18
Redwood City 16
Düsseldorf 15
Washington 15
Milan 13
Pisa 12
Munich 11
Turin 11
Boston 10
Hefei 10
Jakarta 10
Nürnberg 10
Boardman 9
Helsinki 9
Norwalk 9
Paris 9
Brussels 8
Cambridge 8
Den Haag 8
Nanjing 8
Rotterdam 8
New York 7
Philadelphia 7
Kunming 6
Novi Sad 6
Pune 6
Guangzhou 5
Volpago Del Montello 5
Changchun 4
Chengdu 4
Eitensheim 4
Lahore 4
Liverpool 4
Mountain View 4
Ottawa 4
Provo 4
San Diego 4
San Jose 4
Shanghai 4
Bologna 3
Dallas 3
Des Moines 3
Detroit 3
Hangzhou 3
Heidelberg 3
Jinan 3
Johannesburg 3
Kharkiv 3
Limoges 3
Los Angeles 3
Nanchang 3
Piemonte 3
Tianjin 3
Verona 3
Alba 2
Appiano Gentile 2
Central 2
Costa Mesa 2
Erlangen 2
Falls Church 2
Fuzhou 2
Genoa 2
Grugliasco 2
Hong Kong 2
Lachine 2
Los Corrales de Buelna 2
New Delhi 2
Québec 2
Redmond 2
Slough 2
Wroclaw 2
Zhengzhou 2
Aalburg 1
Adelaide 1
Ain Youcef 1
Totale 2.817
Salva come PNG Salva come JPEG
Nome #
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells 283
The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status. 202
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 145
Immunoglobulin variable heavy-chain (Ig Vh) mutational status and tumor microenvironment interactions in B-cell chronic lymphocytic leukaemia 133
CD157: From Myeloid Cell Differentiation Marker to Therapeutic Target in Acute Myeloid Leukemia. 130
CD157 reduces acutemyeloid leukemia cell sensitivity tocytarabine through upregulation of MCL-1 anti-apoptotic protein 121
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma 120
IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 117
CD157 REGULATES THE SENSITIVITY OF ACUTE MYELOID LEUKEMIA CELLS TO CHEMOTHERAPY BY MODULATING THE APOPTOTIC RESPONSE 116
The Mevalonate Pathway As a Metabolic Target to Circumvent Multidrug-Resistance in Chronic Lymphocytic Leukemia Cells 113
Phenotypic and Functional Features of V{gamma}9/V{delta}2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells 113
THE LOCAL MICROENVIRONMENT PLAYS A DIFFERENT ROLE IN THE SURVIVAL OF TUMOR CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH MUTATED AND UNMUTATED IMMUNOGLOBULIN (IG) VH GENES 111
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy. 109
Targeting the mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells 105
IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS 105
The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL) 100
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells 98
IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals 96
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA 96
Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross Talk between V{gamma}9V{delta}2 T Cells, {alpha}{beta} CD8+ T Cells, Regulatory T Cells, and Dendritic Cells 95
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis 95
Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia 94
Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL) 91
Distribution of T-cell signalling molecules in human myeloma 89
CD38 stimulation lowers the activation threshold and enhances the alloreactivity of cord blood T cells by activating the phosphatidylinositol 3-kinase pathway and inducing CD73 expression. 88
Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients. 88
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma 87
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells. 87
PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 86
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID 84
THE SURVIVAL OF TUMOR CELLS IN IGVH UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA IS HIGHLY DEPENDENT ON EXOGENOUS SIGNALS DELIVERED BY THE TUMOR MICROENVIRONMENT 83
Distribution of γδ T cells in patients with hematological malignancies 83
Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells 82
null 80
Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex. 79
Myeloma cells drive the maturation of dendritic cells versus a Th2-promoting phenotype which impairs T-cell activation. 76
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THEIDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENS INCHRONIC LYMPHOCYTIC LEUKEMIA 74
The anaplastic lymphoma kinase as an oncogene in solid tumors 73
IGHV UNMUTATED CLL B CELLS ARE MORE PRONE TO SPONTANEOUS APOPTOSIS AND DEPEND FROM THE ANTI-APOPTOTIC EFFECT OF ENVIRONMENTAL SIGNALS 73
Generation of anti-tumour activity by OKT3-stimulation in multiple myeloma: in vitro inhibition of autologous haemopoiesis. 70
CEP-18770: a novel orally-active proteasome inhibitor with a tumor-selective pharmacological profile competitive with bortezomib 67
Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion. 65
MYELOMA CELLS DRIVE THE MATURATION OF DENDRITIC CELLS VERSUS A TH2-PROMOTING PHENOTYPE WHICH IMPAIRS T-CELL ACTIVATION 64
Increased expression of inactive MHC class-I specific killer inhibitory receptor CD94 in CD8+ cells of myeloma patients 61
Selective induction of CD73 expression in human lymphocytes by CD38 ligation: a novel pathway linking signal transducers with ecto-enzyme activities 55
Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells 53
Sequential administration of OKT3 (anti-CD3) and interleukin-2 in two patients with chemoresistant hematological disease. 48
Idiotypic reactive T cells 44
The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL) 42
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma 28
Totale 4.697
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.347
article - articoli 0
book - libri 0
conference - conferenze 7.723
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.070
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020389 0 0 0 0 0 95 86 39 30 64 45 30
2020/2021519 63 38 26 15 65 10 33 21 74 34 78 62
2021/2022664 21 3 7 49 32 7 134 37 9 83 172 110
2022/2023791 91 87 18 68 69 192 50 54 79 22 41 20
2023/2024371 50 72 23 18 20 76 4 38 0 11 16 43
2024/2025564 3 55 29 88 344 45 0 0 0 0 0 0
Totale 4.697